With FDA-requested toxicology reports in hand, Quantum is preparing to seek clearance for stating the first trial of Lucid-MS ...

New clinical trial data show children with MS may benefit as much from treatment with Ocrevus as Gilenya – and for some outcomes, more.

A new study found that combining cognitive behavioral therapy (CBT) and a wakefulness medication significantly improved levels of fatigue in patients with multiple sclerosis (MS). The findings may ...

A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the ...

Background Multiple sclerosis (MS) is a common autoimmune illness that causes inflammation, demyelination and neurological damage. Symptom relief and immunotherapy are part of the treatment, but ...

Many if not most people in and around the MS community will know there are different classifications of multiple sclerosis. We all know of relapsing-remitting MS (RRMS), with its on-again, off-again ...

People with multiple sclerosis appear to have higher rates of thyroid problems than the general population. The link isn’t clear, but shared pathways and MS medication side effects may play a role. MS ...

"AI-assisted medication management represents a powerful opportunity for critical and timely healthcare transformation to improve patient care, health system margins, and providers' experiences, all ...